Clinical Trials Directory

Trials / Completed

CompletedNCT04422587

Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Status
Completed
Phase
Study type
Observational
Enrollment
1,860 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

This research aims to improve our knowledge of the epidemiology of patients consulting in the COvid-19 Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID-19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. A central issue of this diagnostic strategy will be to be rapid, since the diagnosis will have to be made in the context of significant flows, with a need to quickly refer patients to the most suitable downstream service, while limiting the risk contamination of caregivers and vulnerable patients if a COVID-19 + patient is admitted to an unsuitable service. However, virological tests do not currently allow rapid results for COVID-19. Research project of investigatory aims to develop a predictive model of the risk of being COVID-19 positive for patients admitted to the emergency room for acute dyspnea.

Conditions

Interventions

TypeNameDescription
OTHERRECOP unit patientAll patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified.

Timeline

Start date
2020-03-13
Primary completion
2020-06-05
Completion
2020-06-07
First posted
2020-06-09
Last updated
2020-11-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04422587. Inclusion in this directory is not an endorsement.